Stereotactic Breast Biopsy of Nonpalpable Lesions: Determinants of Ductal Carcinoma in Situ Underestimation Rates
Roger J. Jackman, Steven J. Adler(Unknown), W. Phil Evans(The University of Texas Southwestern Medical Center), Thomas R. Richardson, Rachel F. Brem(George Washington University), Fred Burbank(Mission Heritage Medical Group), Kathy Schilling(Radboud University Nijmegen), Steve H. Parker, Daniel E. Lehrer, Anne A. Smid, Mary C. Lechner, Harriet B. Borofsky, Alan B. Wray, Cheng‐Han Lee(National Tsing Hua University), Harvey M. Goldstein, Thomas H. Helbich(Vienna General Hospital)
Cited by 343
Related Papers
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
|CA A Cancer Journal for Clinicians|2003|781
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists
|JNCI Journal of the National Cancer Institute|2018|674
Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System
|Radiology|2018|601
Use of mutation profiles to refine the classification of endometrial carcinomas
|The Journal of Pathology|2012|299
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
|Modern Pathology|2013|291